Latest Articles

  • Antimicrobial Resistance in Neisseria Gonorrhoeae
    Roselyn J. Rice, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 97;

    Many of the N gonorrhoeae strains seen today are impervious to the relatively inexpensive drugs advocated for primary treatment in earlier years.

  • Stereotactic biopsy of nonneoplastic lesions in adults
    Donald M. Whiting, MD, Gene H. Barnett, MD, Melinda L. Estes, MD, Cathy A. Sila, MD, Richard A. Rudick, MD, Samuel J. Hassenbusch, MD, PhD and Charles F. Lanzieri, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 48-55;

    Stereotactic biopsy is useful in identifying non-neoplastic intracranial lesions when the diagnosis was unclear by conventional means. An accompanying commentary puts the results in perspective.

  • America and death: reflections on euthanasia
    Steven G. Post, PhD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 58-60;
  • Consent to treatment with zidovudine among HIV-infected patients
    Kwan Kew Lai, DMD, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 45-47;

    A high percentage of HIV-infected patients, both asymptomatic and mildly symptomatic, are consenting to zidovudine therapy, despite the risk for serious adverse effects associated with this agent.

  • Erratum
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 109;
  • Spirometry: a key diagnostic test in pulmonary medicine
    James K. Stoller, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 75-78;

    Spirometry permits diagnosis of a wide range of diseases and can be used to reinforce medical advice to modify harmful behavior, such as cigarette smoking.

  • A new quality of life questionnaire for patients with inflammatory bowel disease
    Goran Hellers, MD, PhD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 56-57;
  • Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic
    Alan Bakst, PharmD, Gabriel Vanerio, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 79-86;

    This agent appears to be well tolerated, with a low incidence of both short-term and long-term side effects. However, more clinical experience is needed to better define its antiarrhythmic role.

  • Commentary
    Robert M. Herndon, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 55;
  • Quality of life assessment by patients with inflammatory bowel disease
    Richard G. Farmer, MD, Kirk A. Easley, MS and Janice M. Farmer, MSSA, LISW
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 35-42;

    Patients evaluated their quality of life on a questionnaire designed to more accurately reflect treatment outcome and to act as a tool for quality assurance assessment.

Pages